a developer of products for severe immune-inflammatory disorders
Industry Biotechnology
A.I.dvisor tells us that EQ and MTNB have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EQ and MTNB's prices will move in lockstep.